Toyota City, Japan, Nov 5, 2024 – (JCN Newswire via SeaPRwire.com) – TOYOTA GAZOO Racing completed a thrilling fightback to overcome challenges and retain its FIA World Endurance Championship (WEC) title when the 2024 season came to a dramatic conclusion in the 8 Hours of Bahrain. Starti […]

TOKYO, Nov 5, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. announced today that Eisai Innovation,Inc. has been selected as a registered venture capital (Registered VC) of the Strengthening Program for P […]

TOKYO, Nov 4, 2024 – (JCN Newswire via SeaPRwire.com) – Asahi Kasei Corporation (Asahi Kasei) and Honda Motor Co., Ltd. (Honda) announced today that the two companies have signed a shareholders’ agreement to convert an existing Asahi Kasei subsidiary in Canada into a joint venture compan […]

TOKYO and CAMBRIDGE, Mass., Nov 1, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd.  and Biogen Inc. announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. b […]

HIROSHIMA, Japan, Oct 31, 2024 – (JCN Newswire via SeaPRwire.com) – Mazda Motor Corporation today launched a redesigned corporate website. Amid growing awareness and interest in sustainability, the company redesigned its website to provide stakeholders visiting the corporate website with […]

Toyota City, Japan, Oct 31, 2024 – (JCN Newswire via SeaPRwire.com) – Today, Toyota Motor Corporation (hereafter, Toyota) and Nippon Telegraph and Telephone Corporation (hereafter, NTT) have agreed to a joint initiative in the field of mobility and AI/telecommunications with the aim of r […]

TOKYO and CAMBRIDGE, Mass., Oct 31, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc.  announced today that the latest findings for lecanemab-irmb (U.S. brand name: LEQEMBI®), an anti-amyloid beta (Aβ) protofibril* antibody for the treatment of early Alzheimer’s d […]